Detalhe da pesquisa
1.
RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma.
Ann Hematol
; 102(7): 1773-1787, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171597
2.
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
N Engl J Med
; 380(1): 45-56, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501490
3.
Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma.
Blood
; 136(23): 2628-2637, 2020 12 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785666
4.
Comparing Informants for Mental Health Screening at the Preschool Level.
School Psych Rev
; 51(5): 589-608, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36352894
5.
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol
; 22(10): 1403-1415, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34516954
6.
Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Patients with Lymphoma.
Biol Blood Marrow Transplant
; 26(1): 157-161, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31521818
7.
Correction to: REMIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (polaBR), CART therapies, and lenalidomide/rituximab (R2) based on realworld data in patients with relapsed/refractory diffuse large Bcell lymphoma.
Ann Hematol
; 102(9): 2643-2644, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37432417
8.
Impact of Fixed-Duration Oral Targeted Therapies on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.
Curr Oncol
; 30(5): 4483-4498, 2023 04 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232797
9.
Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results.
Blood Adv
; 7(11): 2283-2286, 2023 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044388
10.
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
Transplant Cell Ther
; 29(1): 34.e1-34.e7, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36243319
11.
Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study.
Clin Lymphoma Myeloma Leuk
; 23(7): 515-526, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37076367
12.
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.
Transplant Cell Ther
; 28(3): 145-151, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954149
13.
Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study.
Clin Cancer Res
; 28(18): 4003-4017, 2022 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35674661
14.
Impact of Oral Targeted Therapy on the Economic Burden of Chronic Lymphocytic Leukemia in Canada.
Curr Oncol
; 28(1): 332-345, 2021 01 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33435341
15.
Patient-reported long-term quality of life after tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv
; 4(4): 629-637, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32074277
16.
Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.
Leuk Res
; 79: 75-80, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30654975
17.
Tisagenlecleucel in relapsed/refractory diffuse large B-cell lymphoma patients without measurable disease at infusion.
Blood Adv
; 3(14): 2230-2236, 2019 07 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31332046
18.
Retrospective study of intravascular large B-cell lymphoma cases diagnosed in Quebec: A retrospective study of 29 case reports.
Medicine (Baltimore)
; 96(5): e5985, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-28151891
19.
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma.
Blood Adv
; 6(16): 4816-4820, 2022 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-35687492
20.
Management and prognosis of 66 patients with B-cell non-Hodgkin lymphoma presenting with initial spinal cord compression: a French retrospective multicenter study.
Leuk Lymphoma
; 56(7): 2025-31, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25347431